Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 16;9(2):160.
doi: 10.3390/vaccines9020160.

COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates

Affiliations
Review

COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates

Malik Sallam. Vaccines (Basel). .

Abstract

Utility of vaccine campaigns to control coronavirus 2019 disease (COVID-19) is not merely dependent on vaccine efficacy and safety. Vaccine acceptance among the general public and healthcare workers appears to have a decisive role in the successful control of the pandemic. The aim of this review was to provide an up-to-date assessment of COVID-19 vaccination acceptance rates worldwide. A systematic search of the peer-reviewed English survey literature indexed in PubMed was done on 25 December 2020. Results from 31 peer-reviewed published studies met the inclusion criteria and formed the basis for the final COVID-19 vaccine acceptance estimates. Survey studies on COVID-19 vaccine acceptance rates were found from 33 different countries. Among adults representing the general public, the highest COVID-19 vaccine acceptance rates were found in Ecuador (97.0%), Malaysia (94.3%), Indonesia (93.3%) and China (91.3%). However, the lowest COVID-19 vaccine acceptance rates were found in Kuwait (23.6%), Jordan (28.4%), Italy (53.7), Russia (54.9%), Poland (56.3%), US (56.9%), and France (58.9%). Only eight surveys among healthcare workers (doctors and nurses) were found, with vaccine acceptance rates ranging from 27.7% in the Democratic Republic of the Congo to 78.1% in Israel. In the majority of survey studies among the general public stratified per country (29/47, 62%), the acceptance of COVID-19 vaccination showed a level of ≥70%. Low rates of COVID-19 vaccine acceptance were reported in the Middle East, Russia, Africa and several European countries. This could represent a major problem in the global efforts to control the current COVID-19 pandemic. More studies are recommended to address the scope of COVID-19 vaccine hesitancy. Such studies are particularly needed in the Middle East and North Africa, Sub-Saharan Africa, Eastern Europe, Central Asia, Middle and South America. Addressing the scope of COVID-19 vaccine hesitancy in various countries is recommended as an initial step for building trust in COVID-19 vaccination efforts.

Keywords: COVID-19; SARS-CoV-2; anti-vaccination; coronavirus; vaccination coverage rates; vaccine acceptance; vaccine hesitancy; vaccine rejection.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the study selection process.
Figure 2
Figure 2
COVID-19 vaccine acceptance rates worldwide. For countries with more than one survey study, the vaccine acceptance rate of the latest survey was used in this graph. The estimates were also based on studies from the general population, except in the following cases where no studies from the general public were found (Australia: parents/guardians; DRC: healthcare workers; Hong Kong: healthcare workers; Malta: healthcare workers).

References

    1. MacDonald N.E., Sage Working Group on Vaccine Hesitancy Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33:4161–4164. doi: 10.1016/j.vaccine.2015.04.036. - DOI - PubMed
    1. SAGE Working Group on Vaccine Hesitancy Report of the SAGE Working Group on Vaccine Hesitancy. [(accessed on 26 December 2020)]; Available online: https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WOR....
    1. Gowda C., Dempsey A.F. The rise (and fall?) of parental vaccine hesitancy. Hum. Vaccines Immunother. 2013;9:1755–1762. doi: 10.4161/hv.25085. - DOI - PMC - PubMed
    1. Kumar D., Chandra R., Mathur M., Samdariya S., Kapoor N. Vaccine hesitancy: Understanding better to address better. Isr. J. Health Policy Res. 2016;5:2. doi: 10.1186/s13584-016-0062-y. - DOI - PMC - PubMed
    1. Daley M.F., Narwaney K.J., Shoup J.A., Wagner N.M., Glanz J.M. Addressing Parents’ Vaccine Concerns: A Randomized Trial of a Social Media Intervention. Am. J. Prev. Med. 2018;55:44–54. doi: 10.1016/j.amepre.2018.04.010. - DOI - PMC - PubMed

LinkOut - more resources